Leerink Partners Downgrades 2seventy bio to Market Perform, Lowers Price Target to $5

Benzinga · 3d ago
Leerink Partners analyst Daina Graybosch downgrades 2seventy bio (NASDAQ:TSVT) from Outperform to Market Perform and lowers the price target from $9 to $5.